Drug Screening Key Players and their Developments
The global drug screening market size was estimated at US$ 6.15 billion in 2023 and is projected to grow to US$ 10.34 billion by 2034, rising at a compound annual growth rate (CAGR) of 4.84% from 2024 to 2034.
Top Companies in the Drug Screening Market
- Cordant Health Solutions
- Sciteck, Inc.
- CareHealth America
- Clinical Reference Laboratory, Inc.
- Laboratory Corporation of America Holdings
- Agilent Technologies, Inc.
- ACM Global Laboratories.
- Bio-Rad Laboratories, Inc.
- Siemens Healthcare GmbH
- American Bio Medica Corporation
- Thermo Fisher Scientific, Inc.
- Alere Inc.
- Quidel Corporation
- Synergy Health plc.
- F. Hoffmann-La Roche Ltd.
- Abbott
- Shimadzu Medical Pvt. Ltd.
- Quest Diagnostics Incorporated
- BioMerieux SA
- Express Diagnostics Int’l, Inc.
- Biomedical Diagnostics
- Danaher
Recent Announcements by Industry Leaders
In January 2024, Micro-Distributing, Inc. and ABK Remote Drug Testing, Inc., the owners of eRAMxTM Live Remote Drug Testing, have announced the establishment of a strategic partnership. The businesses will provide the first and only live, 24/7 remote drug testing service in the U.S.
Recent Developments in the Drug Screening Market
- In October 2024, Broughton introduced the most recent edition of Tox HQ, an online data-driven application that enables clients to discreetly submit their goods for toxicological evaluation in an effort to streamline the toxicity assessment, testing, and regulatory consulting processes.
- In October 2024, Beijing-based ICE Bioscience and SPT Labtech established a collaborative lab devoted to advancements in life sciences automation and intelligent drug screening.
